Follicle-stimulating_hormone_beta_subunit
Category
Follicle-stimulating_hormone_beta_subunit Brand names, Follicle-stimulating_hormone_beta_subunit Analogs
Follicle-stimulating_hormone_beta_subunit Brand Names Mixture
No information avaliable
Follicle-stimulating_hormone_beta_subunit Chemical_Formula
C975H1513N267O304S26
Follicle-stimulating_hormone_beta_subunit RX_link
http://www.rxlist.com/cgi/generic2/thyrotropin.htm
Follicle-stimulating_hormone_beta_subunit fda sheet
Follicle-stimulating_hormone_beta_subunit msds (material safety sheet)
Follicle-stimulating_hormone_beta_subunit Synthesis Reference
No information avaliable
Follicle-stimulating_hormone_beta_subunit Molecular Weight
22672.9
Follicle-stimulating_hormone_beta_subunit Melting Point
No information avaliable
Follicle-stimulating_hormone_beta_subunit H2O Solubility
No information avaliable
Follicle-stimulating_hormone_beta_subunit State
Liquid
Follicle-stimulating_hormone_beta_subunit LogP
-0.330
Follicle-stimulating_hormone_beta_subunit Dosage Forms
Powder for solution; Solution (IM injection)
Follicle-stimulating_hormone_beta_subunit Indication
For detection of residueal or recurrent thyroid cancer
Follicle-stimulating_hormone_beta_subunit Pharmacology
Binding of thyrotropin alfa to TSH receptors on normal thyroid epithelial cells or on well-differentiated thyroid cancer tissue stimulates iodine uptake and organification. Thyrogen is an exogenous source of human TSH that offers an additional diagnostic tool in the follow-up of patients with a history of well-differentiated thyroid cancer.
Follicle-stimulating_hormone_beta_subunit Absorption
No information avaliable
Follicle-stimulating_hormone_beta_subunit Toxicity
No information avaliable
Follicle-stimulating_hormone_beta_subunit Patient Information
No information avaliable
Follicle-stimulating_hormone_beta_subunit Organisms Affected
Humans and other mammals
